These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 19008239
1. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy. Sredniawa B, Lenarczyk R, Kowalski O, Pruszkowska-Skrzep P, Kowalczyk J, Musialik-Lydka A, Cebula S, Kalarus Z. Europace; 2009 Jan; 11(1):106-14. PubMed ID: 19008239 [Abstract] [Full Text] [Related]
2. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy. Shalaby A, El-Saed A, Voigt A, Albany C, Saba S. Pacing Clin Electrophysiol; 2008 May; 31(5):575-9. PubMed ID: 18439171 [Abstract] [Full Text] [Related]
3. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy. Castel MA, Méndez F, Tamborero D, Mont L, Magnani S, Tolosana JM, Berruezo A, Godoy M, Sitges M, Vidal B, Roig E, Brugada J. Europace; 2009 Mar; 11(3):338-42. PubMed ID: 19136491 [Abstract] [Full Text] [Related]
4. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry. Gasparini M, Lunati M, Santini M, Tritto M, Curnis A, Bocchiardo M, Vincenti A, Pistis G, Valsecchi S, Denaro A, INSYNC/INSYNC ICD ITALIAN Registry Investigators. Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128 [Abstract] [Full Text] [Related]
6. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M, Verboven Y, Tavazzi L. J Am Coll Cardiol; 2008 Aug 05; 52(6):438-45. PubMed ID: 18672164 [Abstract] [Full Text] [Related]
12. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population. Foley PW, Chalil S, Khadjooi K, Smith RE, Frenneaux MP, Leyva F. Europace; 2008 Nov 05; 10(11):1302-7. PubMed ID: 18827063 [Abstract] [Full Text] [Related]
15. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial. Boidol J, Średniawa B, Kowalski O, Szulik M, Mazurek M, Sokal A, Pruszkowska-Skrzep P, Kukulski T, Kalarus Z, Lenarczyk R, Triple-Site Versus Standard Cardiac Resynchronisation Trial (TRUST CRT) Investigators. Europace; 2013 Jun 05; 15(6):835-44. PubMed ID: 23487543 [Abstract] [Full Text] [Related]
16. Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy. Mangiavacchi M, Gasparini M, Genovese S, Pini D, Klersy C, Bragato R, Andreuzzi B, Municinò A, Regoli F, Galimberti P, Ceriotti C, Gronda E. Pacing Clin Electrophysiol; 2008 Nov 05; 31(11):1425-32. PubMed ID: 18950300 [Abstract] [Full Text] [Related]
19. Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A. Europace; 2011 Aug 05; 13(8):1174-9. PubMed ID: 21561903 [Abstract] [Full Text] [Related]